412 related articles for article (PubMed ID: 20189943)
21. Telavancin: in vitro activity against staphylococci in a biofilm model.
Gander S; Kinnaird A; Finch R
J Antimicrob Chemother; 2005 Aug; 56(2):337-43. PubMed ID: 15972312
[TBL] [Abstract][Full Text] [Related]
22.
Zheng JX; Tu HP; Sun X; Xu GJ; Chen JW; Deng QW; Yu ZJ; Qu D
J Med Microbiol; 2020 Jan; 69(1):120-131. PubMed ID: 31916929
[No Abstract] [Full Text] [Related]
23. Vancomycin promotes the bacterial autolysis, release of extracellular DNA, and biofilm formation in vancomycin-non-susceptible Staphylococcus aureus.
Hsu CY; Lin MH; Chen CC; Chien SC; Cheng YH; Su IN; Shu JC
FEMS Immunol Med Microbiol; 2011 Nov; 63(2):236-47. PubMed ID: 22077227
[TBL] [Abstract][Full Text] [Related]
24. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
[TBL] [Abstract][Full Text] [Related]
25. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus.
Mirani ZA; Jamil N
J Basic Microbiol; 2011 Apr; 51(2):191-5. PubMed ID: 20967790
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW
Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864
[TBL] [Abstract][Full Text] [Related]
27. A dynamic in vitro model for evaluating antimicrobial activity against bacterial biofilms using a new device and clinical-used catheters.
García I; Conejo Mdel C; Ojeda A; Rodríguez-Baño J; Pascual A
J Microbiol Methods; 2010 Dec; 83(3):307-11. PubMed ID: 20888868
[TBL] [Abstract][Full Text] [Related]
28. The combination of ultrasound with antibiotics released from bone cement decreases the viability of planktonic and biofilm bacteria: an in vitro study with clinical strains.
Ensing GT; Neut D; van Horn JR; van der Mei HC; Busscher HJ
J Antimicrob Chemother; 2006 Dec; 58(6):1287-90. PubMed ID: 17041238
[TBL] [Abstract][Full Text] [Related]
29. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms.
Bakkiyaraj D; Pandian SK
Biofouling; 2010 Aug; 26(6):711-7. PubMed ID: 20706890
[TBL] [Abstract][Full Text] [Related]
31. Disruption of Staphylococcus epidermidis biofilms by medicinal maggot Lucilia sericata excretions/secretions.
Harris LG; Bexfield A; Nigam Y; Rohde H; Ratcliffe NA; Mack D
Int J Artif Organs; 2009 Sep; 32(9):555-64. PubMed ID: 19856274
[TBL] [Abstract][Full Text] [Related]
32. Living cells of Staphylococcus aureus immobilized onto the capillary surface in electrochromatography: a tool for screening of biofilms.
Chen J; Fallarero A; Määttänen A; Sandberg M; Peltonen J; Vuorela PM; Riekkola ML
Anal Chem; 2008 Jul; 80(13):5103-9. PubMed ID: 18505269
[TBL] [Abstract][Full Text] [Related]
33. Impact of oleic acid (cis-9-octadecenoic acid) on bacterial viability and biofilm production in Staphylococcus aureus.
Stenz L; François P; Fischer A; Huyghe A; Tangomo M; Hernandez D; Cassat J; Linder P; Schrenzel J
FEMS Microbiol Lett; 2008 Oct; 287(2):149-55. PubMed ID: 18754790
[TBL] [Abstract][Full Text] [Related]
34. MRT letter: Spatial distribution of vancomycin-induced damage in Staphylococcus epidermidis biofilm: an electron microscopic study.
Singh R; Ray P; Das A; Sharma M
Microsc Res Tech; 2010 Jul; 73(7):662-4. PubMed ID: 20572203
[TBL] [Abstract][Full Text] [Related]
35. Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.
Begic D; von Eiff C; Tsuji BT
J Antimicrob Chemother; 2009 May; 63(5):977-81. PubMed ID: 19304733
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
[TBL] [Abstract][Full Text] [Related]
37. The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms.
Di Poto A; Sbarra MS; Provenza G; Visai L; Speziale P
Biomaterials; 2009 Jun; 30(18):3158-66. PubMed ID: 19329182
[TBL] [Abstract][Full Text] [Related]
38. Maggot metabolites and their combinatory effects with antibiotic on Staphylococcus aureus.
Arora S; Baptista C; Lim CS
Ann Clin Microbiol Antimicrob; 2011 Feb; 10():6. PubMed ID: 21299858
[TBL] [Abstract][Full Text] [Related]
39. Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.
Smirnova MV; Lubenko IY; Portnoy YA; Zinner SH; Firsov AA
Int J Antimicrob Agents; 2007 Feb; 29(2):165-9. PubMed ID: 17207607
[TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
Lee JY; Ko KS; Peck KR; Oh WS; Song JH
J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
